Lung cancer conference set for May 8

Vanderbilt-Ingram Cancer Center will host “The Future of Lung Cancer Care,” a one-day educational event scheduled for May 8 from 8:30 a.m. to 2:30 p.m. at the Nashville Marriott at Vanderbilt University.

The conference will focus on recent improvements in patient outcomes and survival resulting from early detection, advanced imaging, minimally invasive procedures, and breakthroughs in targeted and immune-based therapies. Those improvements have resulted in the five-year survival rate nearly doubling over a decade, according to the State of Lung Cancer report from the American Lung Association.

The conference will feature nationally and internationally known experts.

• Daniel Sterman, MD, director of the Multidisciplinary Pulmonary Oncology Program at New York University Langone Health, will speak about “Interventional Pulmonology: Bronchoscopically Delivered Treatment of Early Lung Cancer.”
• Mohamed Shanshal, MBChB, assistant professor of Medicine in the Division of Hematology and Oncology at Vanderbilt Health and clinical director of Thoracic Oncology, will address “Medical Oncology: Integrating Immunotherapy, Targeted Therapy, and Beyond.”
• Joseph Mammarappallil, MD, PhD, associate professor of Radiology and cardiothoracic imaging specialist at Duke University School of Medicine, will discuss “Interventional Radiology: Imaging-Driven Precision and Local Control.”
• Several Vanderbilt Health lung cancer experts will also speak.

Discussion topics include advances in early detection and diagnostic precision, breakthroughs in minimally invasive biopsy and surgical techniques, the expanding role of targeted therapy and immunotherapy, evolving approaches to survivorship, and supportive care. The conference is open to families, caregivers, clinicians, trainees and anyone interested in lung cancer care. Physicians who attend the conference may claim 7.0 AMA PRA Category 1 credits toward continuing medical education.

Reservations can be made via Eventbrite.